ライフサイエンスコーパス: dengue fever

1 key event in the pathogenesis of complicated dengue fever.

2 e flaviviral agents causing Yellow fever and Dengue fever.

3 ater in subjects with DHF than in those with dengue fever.

4 ensify or extend the transmission season for dengue fever.

5 ndothelial damage is a key feature of severe dengue fever.

6 an cause severe diseases such as malaria and dengue fever.

7 orm control planning to reduce the burden of dengue fever.

8 utility of ultrasound as a screening tool in dengue fever.

9 es showed that ZIKV infection most resembles dengue fever.

10 were positive and 95 cases were negative for dengue fever.

11 tection of non-structural protein 1 (NS1) of dengue fever.

12 ally helpful in making an early diagnosis of dengue fever.

13 are in clinical trials for the treatment of dengue fever.

14 associated with susceptibility to secondary dengue fever.

15 in PBMC isolated from individuals with acute dengue fever.

16 ines or antiviral therapies are approved for dengue fever.

17 several vaccines are in clinical trials for dengue fever.

18 spectively enrolled 99 adults with dengue-40 dengue fever, 46 dengue with warning signs and 13 severe

19 opulations and reduce the local incidence of dengue fever(8).

20 ological tests were also used for diagnosing dengue fever, 93 cases were seropositive and 67 cases we

21 sence of specific treatment conspire to make dengue fever a global public health threat.

22 iruses has led to the resurgence of epidemic dengue fever (a self-limited flu-like syndrome) and the

23 Dengue fever, a prevalent and rapidly spreading arbovira

24 Dengue fever, a tropical vector-borne disease, is a lead

25 of female mosquitoes of the major vector of Dengue fever, Aedes aegypti, is cyclic because of its de

26 Dengue fever affects millions globally, predominantly in

27 e polymerase chain reaction in patients with dengue fever and a DENV-infected mice model.

28 emokines have been reported in patients with dengue fever and are proposed to contribute to the patho

29 rities, and control strategies for combating dengue fever and breeding sites of Aedes mosquitoes in H

30 Dengue fever and dengue hemorrhagic fever are significan

31 niques are needed for the early diagnosis of dengue fever and dengue hemorrhagic fever during the acu

32 mosquito-borne flaviviruses responsible for dengue fever and dengue hemorrhagic fever.

33 of dengue virus are the causative agents of dengue fever and dengue hemorrhagic fever.

34 l model for dengue virus (DEN), which causes dengue fever and dengue hemorrhagic fever/dengue shock s

35 Dengue virus (DEN), a flavivirus, causes dengue fever and dengue hemorrhagic fever/dengue shock s

36 Dengue virus (DEN) causes dengue fever and dengue hemorrhagic fever/dengue shock s

37 The four dengue virus (DENV) serotypes cause dengue fever and dengue hemorrhagic fever/dengue shock s

38 DENV-4), each of which is capable of causing dengue fever and dengue hemorrhagic fever/dengue shock s

39 nfounded with other febrile illnesses (e.g., dengue fever and leptospirosis) and point-of-care testin

40 bor the causative agents of diseases such as dengue fever and malaria, afflicting human morbidity and

41 nostic uses, we applied the system to detect dengue fever and molecularly profile cancer cells throug

42 For dengue fever and other seasonal epidemics we show how th

43 for an EDIII-based vaccine candidate against dengue fever and presents a Gateway((R)) plastid transfo

44 es are members of the Flaviviridae and cause dengue fever and the more severe dengue hemorrhagic feve

45 Dengue virus is the causative agent of dengue fever and the more-severe dengue hemorrhagic feve

46 Zika virus as well as diagnostic testing for Dengue fever and West Nile virus.

47 h chorioretinal lesions reported in cases of Dengue fever and West Nile virus.

48 resent the major vectors of African malaria, dengue fever and yellow fever viruses, and lymphatic fil

49 transmission of various diseases, including dengue fever and yellow fever.

50 ites), systemic febrile illness (malaria and dengue fever), and respiratory illnesses predominate.

51 lated SAEs (which included hypersensitivity, dengue fever, and dengue hemorrhagic fever) occurred in

52 ous devastating diseases, including malaria, dengue fever, and sleeping sickness.

53 l protein dengue NS1, an early biomarker for dengue fever, antibody immobilization capacity was 75-fo

54 Coronavirus disease 2019 (COVID-19) and dengue fever are difficult to distinguish given shared c

55 COVID-19 and dengue fever are difficult to distinguish given shared c

56 For example, malaria and dengue fever are febrile illnesses transmitted through m

57 Malaria, Lyme disease, and dengue fever are just a few examples of VBDs that cause

58 mosquito-borne diseases, such as malaria and dengue fever, are reducing mosquito population sizes or

59 almology, Nepal focusing on all instances of dengue fever associated with retinal complications durin

60 Dengue virus infection typically causes mild dengue fever, but, in severe cases, life-threatening den

61 n of infectious diseases such as malaria and dengue fever by vector control of disease-transmitting m

62 Concurrently, dengue fever cases have climbed over the past decade.

63 ethods to address reporting delay in data on dengue fever cases in Puerto Rico from 1990 to 2009 and

64 Dengue fever cases were detected by door-to-door surveil

65 Dengue fever, caused by a mosquito-transmitted virus, is

66 Dengue fever, caused by four distinct serotypes of the d

67 m malaria (chi(2)=37.57, p<0.001); increased dengue fever (chi(2)=135.9, p<0.001); and a widening geo

68 the US, and are vectors of diseases such as dengue fever, chikungunya, and Zika.

69 s at risk of vector-borne diseases including dengue fever, chikungunya, zika, yellow fever, leishmani

70 NCT01030211.Dengue fever commonly results in thrombocytopenia.

71 rotease, in blood samples from patients with dengue fever compared with healthy individuals and a hig

72 Vector-borne diseases such as malaria and dengue fever continue to be a major health concern throu

73 Mosquito-borne diseases such as malaria and dengue fever continue to be a major health problem throu

74 hese discussions, seven key determinants for dengue fever control in Iran were identified.

75 ruses are widespread human pathogens causing dengue fever, dengue hemorrhagic fever, and dengue shock

76 (DENV) causes a range of illness, including dengue fever, dengue hemorrhagic fever, and dengue shock

77 engue virus (DENV) is the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock

78 The causative agent of dengue fever, dengue virus (DENV), is transmitted by mos

79 Dengue fever/dengue hemorrhagic fever is now one of the

80 se, is a predictive biomarker distinguishing dengue fever (DF) and dengue hemorrhagic fever (DHF).

81 duce, which occur exclusively in humans, are dengue fever (DF) and dengue hemorrhagic fever (DHF).

82 reased transmission and geographic spread of dengue fever (DF) and its more severe presentation, deng

83 here dengue occurs are at risk of developing dengue fever (DF) and its severe complications, dengue h

84 Dengue viruses (DEN), causative agents of dengue fever (DF) and more severe dengue hemorrhagic fev

85 vels remained unchanged in those with DHF or dengue fever (DF) during febrile and critical phases.

86 n children with DHF compared with those with dengue fever (DF) early in the course of illness.

87 Dengue fever (DF) epidemics in Australia are caused by i

88 hildren who developed DHF than in those with dengue fever (DF) or other nondengue febrile illnesses (

89 identified the possible threshold to predict dengue fever (DF) outbreaks using Baidu Search Index (BS

90 nging from a mild febrile illness to classic dengue fever (DF) to dengue hemorrhagic fever (DHF), a p

91 m a mild undifferentiated febrile illness to dengue fever (DF) to dengue hemorrhagic fever (DHF), a p

92 propose two differential-equation models of dengue fever (DF) with different levels of complexity an

93 eptors in patients with DHF to patients with dengue fever (DF), a milder form of dengue virus infecti

94 ributed among other febrile illnesses (OFI), dengue fever (DF), and dengue hemorrhagic fever (DHF) ca

95 d into four serotypes (DENV-1-4) that causes Dengue fever (DF), Dengue hemorrhagic Fever (DHF) or Den

96 Dengue patients present a range of symptoms: dengue fever (DF), dengue hemorrhagic fever (DHF), and d

97 orrhagic fever (DHF), versus the more common dengue fever (DF), have been limited to indirect clinica

98 ases, such as tick-borne encephalitis (TBE), dengue fever (DF), West Nile (WN) and yellow fever (YF),

99 atients with dengue experience mild disease, dengue fever (DF), while few develop the life-threatenin

100 engue virus (DENV) is the causative agent of dengue fever (DF).

101 rimary and secondary infection presenting as dengue fever (DF; mild) and dengue hemorrhagic fever (DH

102 Health Organization 2009 guidelines (44 with dengue fever [DF], 51 with DF with warning signs, and 12

103 Dengue fever diagnoses displayed marked seasonality, alt

104 negative ultrasound findings cannot rule out dengue fever due to the low sensitivity of this examinat

105 0 million people worldwide are infected with dengue fever each year.

106 uch an approach may be employed to control a dengue fever epidemic.

107 he most important vector of yellow fever and dengue fever flaviviruses.

108 , that demonstrated the highest incidence of dengue fever from 2013 to 2017 were evaluated for the be

109 All 4 control subjects developed dengue fever from challenge.

110 ety of viruses, e.g., SARS-CoV-2, influenza, dengue fever, hepatitis C virus, HIV, rotavirus and Zika

111 ortality from diarrheal disease, malaria and dengue fever in 2030 and 2050 with current estimates use

112 Photo Quiz article presents a case of acute dengue fever in an American traveler returning from Puer

113 n 1 (NS1 DENV) is considered a biomarker for dengue fever in an early stage.

114 engue-2 virus (strain PUO-218 from a case of dengue fever in Bangkok, Thailand).

115 data for COVID-19 in nine countries and for dengue fever in Brazil; in parallel, estimateR is alread

116 y, and splenomegaly are highly suggestive of dengue fever in clinically suspected cases.

117 ses of heterogeneous distribution pattern of dengue fever in different high-risk areas is limited.

118 early warning and the scientific control of dengue fever in high-risk areas.

119 Dengue virus (DENV) infection causes dengue fever in humans, which can lead to thrombocytopen

120 Here we compare time-series forecasts of dengue fever in Thailand, integrating epidemiological da

121 mate, mosquito density and imported cases on dengue fever in two high-risk areas using Generalized Ad

122 and mosquito density are the key drivers on dengue fever incidence in different high-risk areas of C

123 al analyses of associations between vectors, dengue fever incidence, and climate conditions.

124 Colloquially known as Dengue Fever, infection can cause hemorrhagic disorders

125 many infectious diseases, including malaria, dengue fever, influenza, bacterial sepsis, and severe ac

126 the risk of the mosquito-transmitted disease dengue fever is a concern.

127 Dengue fever is a disease in many parts of the tropics a

128 Dengue fever is a global mosquito-borne viral infectious

129 Dengue fever is a mosquito-borne disease that affects ne

130 Dengue fever is a mosquito-borne viral infection, with r

131 Dengue fever is a mosquito-borne virus that infects 50-1

132 Dengue fever is a mosquitoborne viral illness caused by

133 Dengue fever is a significant threat to military personn

134 Dengue fever is a tropical disease that is transmitted b

135 Dengue fever is an acute febrile infectious disease caus

136 Dengue fever is an important tropical illness for which

137 a practical tool for use in countries where dengue fever is endemic, in conjunction with classical m

138 An ensemble forecast system for dengue fever is first proposed that addresses the diffic

139 ue virus (DENV) from patients with suspected dengue fever is important both for the diagnosis of the

140 Dengue fever is listed among the top ten global health t

141 Dengue fever is one of the most important mosquito-borne

142 Dengue fever is one of the most neglected tropical disea

143 Dengue fever is the most common mosquito transmitted vir

144 Dengue fever is the most frequent arthropod-borne viral

145 Dengue virus (DENV), the etiologic agent of dengue fever, is transmitted during probing of human ski

146 For the control and prevention of dengue fever, it is important to rapidly detect and type

147 olytic diseases such as sickle cell disease, dengue fever, malaria, and sepsis.

148 pread of life-threatening illnesses, such as dengue fever, malaria, and yellow fever.

149 ynamics of mosquito-borne infections such as dengue fever, malaria, chikungunya, and West Nile virus.

150 r the detection of biomarkers of malaria and dengue fever: malaria HRP2, malaria pLDH, and dengue NS1

151 and specificity using an early biomarker of dengue fever, NS-1, as an exemplar and clinically releva

152 ound the rainfall had the indirect effect on dengue fever occurrence in both areas mediated by mosqui

153 nsity of Aedes larvae, climate variables and dengue fever occurrence in the studied high-risk areas o

154 ed that the most important factors affecting dengue fever occurrence were the number of imported case

155 t the effects of projected climate change on dengue fever occurrence, but results have been inconsist

156 ector of arboviral diseases, particularly of Dengue fever, of which there are more than 100 million c

157 genotype) can outcompete viruses that cause dengue fever only (American genotype).

158 mined in a discovery cohort of patients with dengue fever or dengue hemorrhagic fever (DHF) (n = 166)

159 pervasiveness of the infection, hemorrhagic dengue fever or dengue shock syndrome.

160 ptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue(1,2).

161 In June 2024, Iran reported a dengue fever outbreak beginning in Hormozgan province an

162 Predictors of dengue fever outbreaks could provide timely information

163 Eastern Ethiopia has had dengue fever outbreaks in recent years.

164 Louis and dengue fever patients.

165 Mosquito-borne diseases such as malaria and dengue fever pose a major health problem through much of

166 Dengue fever poses a significant public health burden in

167 total of 32 eyes (16 patients; 7 male) with dengue fever (positive serology for NS1 antigen) were en

168 Ocular manifestations in dengue fever remain underrecognized despite reports of v

169 As a common vector-borne disease, dengue fever remains challenging to predict due to large

170 Dengue fever represents a significant medical and socio-

171 e recent increase in the global incidence of dengue fever resulted in over 2.7 million cases in Latin

172 y of literature on the use of ultrasound for dengue fever screening; hence, the primary objective of

173 nstructed to generate real-time forecasts of dengue fever spread dynamics.

174 Numerical results using data for dengue fever suggest that the proportional policy outper

175 Mosquito-borne diseases such as malaria and dengue fever take a large toll on global health.

176 In areas coendemic for malaria and dengue fever, this assay could be used as a rapid, point

177 of clinical symptoms, ranging from classical dengue fever to severe dengue hemorrhagic fever or dengu

178 ectrum of severity in humans from the milder dengue fever to severe disease, or dengue hemorrhagic fe

179 e of clinical manifestations in humans, from dengue fever to the more serious dengue hemorrhagic feve

180 pathologies ranging from the febrile illness dengue fever to the potentially lethal severe dengue dis

181 upled links may facilitate further spread of dengue fever under a changing climate.

182 s are asymptomatic or develop a self-limited dengue fever, up to 1 million clinical cases develop sev

183 f infections which produced a higher risk of dengue fever upon secondary infection are: DEN1 followed

184 logy for other infectious diseases including dengue fever virus and chikungunya virus.

185 dengue diagnostic tests, the MRL Diagnostics Dengue Fever Virus IgM Capture ELISA and the PanBio Rapi

186 entified (mean titer of 107.6 for those with dengue fever vs. 108.5 for patients with DHF, P=.01).

187 by the failure of current methods to control dengue fever, we formulate a mathematical model to asses

188 predictive value of ultrasound in diagnosing dengue fever were 58%, 84%, and 83%, respectively.

189 aterial/A total of 160 patients of suspected dengue fever were included in the study.

190 viruses, the human pathogens responsible for dengue fever, West Nile fever, tick-borne encephalitis,

191 fectious disease cohorts (Hepatitis B and C, Dengue Fever, West Nile Virus and Chagas disease) and an

192 pti, the primary vector for yellow fever and dengue fever, which at approximately 1376 million base p

193 smission of the flaviviruses responsible for dengue fever, yellow fever, and chikungunya.

194 vastating human diseases, including malaria, dengue fever, Zika virus, and others.